Skip to main content
OpenTrials

Clinical trial condition

Nonsquamous Nonsmall Cell Neoplasm of Lung

Explore clinical trials studying Nonsquamous Nonsmall Cell Neoplasm of Lung. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Nonsquamous Nonsmall Cell Neoplasm of Lung trial results

Completed

A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer

NCT03846310

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Arizona Cancer Research Center (ACRC) Tucson, Arizona, United States
  • SCRI Florida Cancer Specialists - South Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists - North Tavares, Florida, United States
  • SCRI Tennessee Oncology - Nashville Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Completed

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

NCT01705184

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Caen - Centre François Baclesse Caen, France
  • Caen - CHU Côte de Nacre Caen, France
  • Centre Hospitalier Chauny, France
View Trial Details
Completed

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

NCT03380871

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of California - Los Angeles Santa Monica, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details
Completed

A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

NCT02259582

Conditions
Carcinoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 45 locations
View Trial Details

Related conditions